FDA Warns Consumers about Counterfeit Alli : RushPRNews - Newswire & Global Press Release Distribution

 
Bookmark and Share

FDA Warns Consumers about Counterfeit Alli

January 19, 2010

Washington, DC (RPRN) 01/19/10 — The counterfeit products contain controlled substance sibutramine

The U.S. Food and Drug Administration is today warning consumers about a counterfeit and potentially harmful version of Alli 60 mg capsules (120 count refill kit).

Preliminary laboratory tests conducted by GlaxoSmithKline (GSK)—the maker of the FDA approved over-the-counter weight-loss product— revealed that the counterfeit version did not contain orlistat, the active ingredient in its product. Instead, the counterfeit product contained the controlled substance sibutramine. Sibutramine is a drug that should not be used in certain patient populations or without physician oversight. Sibutramine can also interact in a harmful way with other medications the consumer may be taking.

Consumers began reporting suspected counterfeit Alli to GSK in early December 2009. GSK has determined that the counterfeit product has been sold over the internet. However, there is no evidence at this time that the counterfeit Alli product has been sold through other channels, such as retail stores.

The counterfeit Alli product looks similar to the authentic product, with a few notable differences. The counterfeit Alli has:

Outer cardboard packaging missing a “Lot” code;

Expiration date that includes the month, day, and year (e.g., 06162010); authentic Alli expiration date includes only the month and year (e.g.,: 05/12);

Packaging in a plastic bottle that has a slightly taller and wider cap with coarser ribbing than the genuine product;

Plain foil inner safety seal under the plastic cap without any printed words; the authentic product seal is printed with “SEALED for YOUR PROTECTION”;

Contains larger capsules with a white powder, instead of small white pellets.

Consumers who believe they have received counterfeit Alli are asked to contact the FDA's Office of Criminal Investigations (OCI) by calling 800-551-3989 or by visiting the OCI Web site (http://www.fda.gov/OCI).

Health care professionals and consumers are encouraged to report adverse events that may be related to the use of these counterfeit products to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, or by mail at: MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787.

 

Media Web Address: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm197857.htm
About the author:

FDA is an agency within the Department of Health and Human Services and consists of seven centers and offices

Click here to see all news from this author/company

Filed Under: FDA- Pharmaceutical news, Health and Fitness, Lifestyle, PRESS RELEASE

RUSH PR NEWS newswire and press release services at rushprnews.com / Anne Howard annehowardpublicist.com

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.

RSSFeed PRESS & SOCIAL MEDIA RELEASES

Newborn Foundation Featured on Global Health Panel at Annual Patient Safety Science and Technology Summit

SAINT PAUL, MN and IRVINE, CA-- 01/23/15 ·  - The Newborn Foundation, an international nonprofit leveraging medical...

Cape Coral Waterfront Estate Known as “The UPS House” to be Sold at February 10th Absolute Auction

Fort Myers, Florida 01/21/15 · Truck Driver Turned Executive Selling Florida Riverfront Dream...

Studio One selects Visual 2000 End2End Suite of Fashion Business Solutions

LONDON, UK 01/20/15 · Visual 2000 International announces manufacturer Studio One  are...

CPD Seminar: How Skill Trade Workers Will be Effected by Express Entry

Vancouver, BC - 01/19/15 · Ashton College Announces Seminar Addressing Express Entry - New...

Dr. Ken Pool, IT Pioneer, dead at 62, leaves a rich legacy in health data standards and public health

ARLINGTON, TX 01/17/15 · With deep sadness  OZ Systems announces the sudden passing...

Dr. Ken Pool, Founder and Chairman of Dallas-based OZ Systems, Dies at 62

ARLINGTON, TX 01/16/15 · It is with deep sadness that OZ Systems announces...

Real Estate Auction – Is It Right for You?

Charlotte, NC 01/12/15 · Luxury homeowners looking to sell their estates face...

Philippines to Host Largest Crowd in Human History

Manila, Philippines 01/12/15 · The largest gathering of humans ever recorded will...

First Dedicated Canadian Bitcoin Price Index Launched

Vancouver, BC 01/08/15 · The Canadian Bitcoin Index (CBIX) created by Vancouver...

OnServe & Learning Brick has expanded to Niagara/Southwestern ON.

Kingston, ON 01/06/15 · Onserve is your trusted IT services company in...

Music Host Network Wants Writers Now!

LOS ANGELES 01/06/15 · The Music Host Network, a music media site...

Identify genuine web traffic from bots and botnets

SAN FRANCISCO 01/06/15 · As a provider of high-quality web traffic, Traffic...

Author Manfred Popp publishes - You can do what I did: lose weight, improve your health, stay fit -

Gaimersheim / Germany 01/06/15 · New book from author Manfred Popp about Weight...